Company
Liberate Bio
Breaking the Barriers of Genetic Medicine So No Patient Is Left Behind
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Liberate Bio
Claim, correct or request removal
Record updated 28 September 2026
About
Liberate Bio enables genetic medicines to access disease-driving cells directly in the body—reprogramming cellular behavior to cure disease.
Funding snapshot
- Total raised
- $31MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $31M2025-10-15
Funding rounds
- Round, 2025
- $31M2025-10-15, Company stated
Loading relationship preview